Diseases and disorders
With one in five Australians now suffering from a neurological, mental health and addiction disorder, and with current treatments often inadequate, we are facing a growing health and social crisis. The economic impact of these conditions is also profound, costing Australia over $45.5 billion each year.
Our researchers are advancing the diagnosis and treatment of these conditions to improve the lives of so many in our community.
Our multidisciplinary academic expertise is focused on key disease areas:
With over 40 types of brain tumours, our researchers are developing new therapies and treatments for the 1,600 Australians diagnosed with brain cancer every year.
Cognitive Neuroscience is an interdisciplinary area of research that combines measurement of brain activity carried out through neuroimaging.
Using the latest technology platforms, Monash Neuroscience researchers are committed to better understanding the human brain and its connections.
Over one million Australians are living with an eating disorder yet less than a quarter of these will receive treatment or support. As eating disorders have the highest mortality rate of any mental health illness, our researchers are investigating treatments for early identification and recovery.
Epilepsy is a neurological disorder of the brain commonly characterised by the tendency to have recurrent seizures, however the disorder can take many forms and affect people differently.
To better understand epilepsy, we’re using advanced machine learning technology to provide epilepsy patients with more accurate and rapid diagnoses.
Multiple sclerosis (MS) is a chronic degenerative disease that affects almost 25,000 Australians and is four times more prevalent in women.
Monash neuroscience researchers are committed to researching the prevention and possible treatments for MS. Some of our research looks at monitoring MS using patient-derived and MRI scan information as well as exploring the effects on the disease during pregnancy.
Neurodegenerative diseases are conditions in which cells in the brain deteriorate, causing problems with how a person moves, thinks and behaves.
Our researchers are making new discoveries in neurodegenerative diseases such as Alzheimer's disease, Parkinson’s disease, spinal muscular atrophy and much more.
The brain is the most complex organ in our body. It undergoes massive developmental change from infancy to early adulthood, particularly in the first 1000 days from conception.
Through the work of the Turner Institute for Brain and Mental Health, our researchers are leading the way in investigating the mechanisms associated with neurodevelopment disorders. These include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), learning disabilities, and cerebral palsy.